For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Vistra. The consensus rating for Vistra is Buy, derived from 6 ...

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that the ...

The former Dynegy Power Plant along the Berm Highway has been closed for nearly 10 years now, and it was demolished in early 2021. Now, the new owners are hosting ...